О. М. Моисеева

12.8k total citations · 2 hit papers
188 papers, 2.1k citations indexed

About

О. М. Моисеева is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, О. М. Моисеева has authored 188 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cardiology and Cardiovascular Medicine, 94 papers in Pulmonary and Respiratory Medicine and 36 papers in Molecular Biology. Recurrent topics in О. М. Моисеева's work include Pulmonary Hypertension Research and Treatments (67 papers), Cardiovascular Function and Risk Factors (21 papers) and Cardiac Valve Diseases and Treatments (17 papers). О. М. Моисеева is often cited by papers focused on Pulmonary Hypertension Research and Treatments (67 papers), Cardiovascular Function and Risk Factors (21 papers) and Cardiac Valve Diseases and Treatments (17 papers). О. М. Моисеева collaborates with scholars based in Russia, United States and Italy. О. М. Моисеева's co-authors include Richard N. Channick, Nazzareno Galiè, Vallerie V. McLaughlin, Ioana R. Preston, Robert P. Frantz, Ekkehard Grünig, Zhi‐Cheng Jing, Tomás Pulido, Zeenat Safdar and Yuichi Tamura and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

О. М. Моисеева

152 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selexipag for the Treatment of Pulmonary Arterial Hypertension

2015 706 citations О. М. Моисеева et al. profile →
Risk stratification and medical therapy of pulmonary arterial hypertension

2018 521 citations О. М. Моисеева et al. profile →

Peers

Countries citing papers authored by О. М. Моисеева

Since Specialization

Citations

This map shows the geographic impact of О. М. Моисеева's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. М. Моисеева with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. М. Моисеева more than expected).

Fields of papers citing papers by О. М. Моисеева

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by О. М. Моисеева. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. М. Моисеева. The network helps show where О. М. Моисеева may publish in the future.

Co-authorship network of co-authors of О. М. Моисеева

This figure shows the co-authorship network connecting the top 25 collaborators of О. М. Моисеева. A scholar is included among the top collaborators of О. М. Моисеева based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with О. М. Моисеева. О. М. Моисеева is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential diagnosis of pericarditis. Part I: Anatomical and physiological characteristics of the pericardium, chest pain syndrome, and pericardial effusion 2025 ·Russian Journal of Cardiology ·(unknown), О. М. Моисеева	0
2	Expert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension 2025 ·Terapevticheskii arkhiv ·И Е Чазова, T. V. Martynyuk, С. Н. Авдеев, (unknown), (unknown), (unknown), (unknown), (unknown), N. M. Danilov, (unknown), (unknown), (unknown), О. М. Моисеева, A. М. Chernyavskiy, (unknown), (unknown)	0
3	Carlino-Like Technique for Retrograde Recanalization of Chronic Thromboembolic Pulmonary Artery Occlusion 2024 ·JACC: Cardiovascular Interventions ·(unknown), (unknown), (unknown), (unknown), О. М. Моисеева, (unknown)	2
4	Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY) 2024 ·Pulmonary Circulation ·Grzegorz Kopeć, Paul R. Forfia, Kohtaro Abe, Amélie Beaudet, Virginie Gressin, Mitja Jevnikar, (unknown), Yan Zhi Tan, О. М. Моисеева, Karen Sheares, Nika Skoro‐Sajer, Mário Terra Filho, Helen Whitford, Zhenguo Zhai, Gustavo A. Heresi	6
5	Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY) 2024 ·Pulmonary Circulation ·Nika Skoro‐Sajer, Karen Sheares, Paul R. Forfia, Gustavo A. Heresi, Mitja Jevnikar, Grzegorz Kopeć, О. М. Моисеева, Mário Terra Filho, Helen Whitford, Zhenguo Zhai, Amélie Beaudet, Virginie Gressin, (unknown), Yan Zhi Tan, Kohtaro Abe	1
6	Assessment of central hemodynamic parameters after pulmonary thrombendarterectomy in patients with chronic thromboembolic pulmonary hypertension 2024 ·Russian Journal of Cardiology and Cardiovascular Surgery ·(unknown), (unknown), (unknown), (unknown), (unknown), О. М. Моисеева, (unknown)	0
7	The Role of NOTCH Pathway Genes in the Inherited Susceptibility to Aortic Stenosis 2024 ·Journal of Cardiovascular Development and Disease ·O. B. Irtyuga, (unknown), (unknown), (unknown), S. I. Tarnovskaya, (unknown), (unknown), (unknown), О. М. Моисеева, (unknown), Mykyta Artomov, Anna Kostareva, Е. V. Shlyakhto	2
8	Association between traditional cardiovascular risk factors and clinical phenotype of hypertrophic cardiomyopathy 2023 ·Arterial’naya Gipertenziya (Arterial Hypertension) ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anna Kostareva, О. М. Моисеева	1
9	INCREASED LEVELS OF PROINFLAMMATORY CYTOKINES IN BLOOD PLASMA IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION 2023 ·Complex Issues of Cardiovascular Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), М. М. Галагудза, О. М. Моисеева	0
10	Inhibition of JAK1,2 Prevents Fibrotic Remodeling of Pulmonary Vascular Bed and Improves Outcomes in the Rat Model of Chronic Thromboembolic Pulmonary Hypertension 2022 ·International Journal of Molecular Sciences ·А. А. Карпов, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alexander Krasichkov, (unknown), О. М. Моисеева, М. М. Галагудза	9
11	Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis) 2022 ·Terapevticheskii arkhiv ·С. Н. Терещенко, И. В. Жиров, О. М. Моисеева, (unknown), А. А. Аншелес, О. Л. Барбараш, А. S. Galyavich, A. Ya. Gudkova, D. A. Zateyshchikov, Anna Kostareva, (unknown), С. В. Недогода, T. B. Pecherina, (unknown), В. Б. Сергиенко	8
12	Idiopathic recurrent pericarditis – a new orphan autoinflammatory disease? A retrospective analysis of cases of idiopathic recurrent pericarditis and a design of а double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of RPH-104 treatment in patients with idiopathic recurrent pericarditis 2021 ·Kardiologiia ·(unknown), (unknown), О. М. Моисеева	3
13	The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study 2021 ·Inflammation Research ·N. V. Lomakin, (unknown), Д. Н. Проценко, Mazurov Vi, (unknown), О. М. Моисеева, (unknown), Vladimir O. Popov, Е. А. Smolyarchuk, И. Г. Гордеев, Mikhail Gilyarov, Daria Fomina, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	35
14	On the possibility to increase sensitivity of diagnostic tests for fixed pulmonary hypertension in heart transplant candidates 2019 ·SHILAP Revista de lepidopterología ·(unknown), А. Е. Баутин, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), О. М. Моисеева, M. Yu. Sitnikova, (unknown)	2
15	Idiopathic recurrent pericarditis — a paradigm shift? 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), О. М. Моисеева	4
16	SEARCH FOR CLINICAL PREDICTORS OF PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC SCLEROSIS 2018 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), О. М. Моисеева	1
17	ROLE OF THE NOTCH1 GENE IN FORMATION OF AORTIC ANEURYSM 2018 ·Russian Journal of Cardiology ·O. B. Irtyuga, (unknown), (unknown), Anna Malashicheva, S. I. Tarnovskaya, Vladimir Uspenskiy, (unknown), О. P. Rotar, Anna Kostareva, О. М. Моисеева	2
18	PURINERGIC SIGNALING RECEPTORS EXPRESSION ON PERIPHERAL T-LYMPHOCYTES OF HEALTHY DONORS 2017 ·А. С. Головкин, М. К. Серебрякова, (unknown), (unknown), (unknown), (unknown), О. М. Моисеева, (unknown), I. V. Kudryavtsev	4
19	Pathogenetic mechanisms of ascending aortic aneurysm of varied aetiology 2013 ·SHILAP Revista de lepidopterología ·O. B. Irtyuga, (unknown), (unknown), (unknown), Anna Malashicheva, О. М. Моисеева	1
20	Comparative analysis of the serum level of autoantibodies as a diagnostic tool of myocardial inflammatory diseases 2012 ·SHILAP Revista de lepidopterología ·О. М. Моисеева, Л. Б. Митрофанова, (unknown), (unknown), (unknown), Alexander Poletaev	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact